Current Vascular Pharmacology

Editor-in-Chief:

Dimitri P. Mikhailidis  
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street, London, NW3 2QG
UK

Back

Become EABM
Become Reviewer



Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge) free to download

Volume:12   Issue: 4
Pp: 549-552
Sibel Ertek and Maciej Banach
DOI: 10.2174/157016111204140702101134

Insulin Resistance in Brain and Possible Therapeutic Approaches

Volume:12   Issue: 4
Pp: 553-564
Sevki Cetinkalp, Ilgin Y. Simsir and Sibel Ertek
DOI: 10.2174/1570161112999140206130426

Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside

Volume:12   Issue: 4
Pp: 565-571
Arrigo F. Cicero, Elisa Tartagni and Sibel Ertek
DOI: 10.2174/15701611113119990120

Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome

Volume:12   Issue: 4
Pp: 572-585
Manfredi Rizzo, Milan Obradovic, Milica Labudovic-Borovic, Dragana Nikolic, Giuseppe Montalto, Ali A. Rizvi, Dimitri P. Mikhailidis and Esma R. Isenovic
DOI: 10.2174/1570161111999131205160756

Patients with Prehypertension - Do we have Enough Evidence to Treat them?

Volume:12   Issue: 4
Pp: 586-597
Michalska Marta, Alberto Zanchetti, Nathan D. Wong, Jolanta Malyszko, Jacek Rysz and Maciej Banach
DOI: 10.2174/15701611113119990126

Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?

Volume:12   Issue: 4
Pp: 598-616
Theodosios D. Filippatos and Moses S. Elisaf
DOI: 10.2174/15701611113119990133

Is there U-turn from Insulin Back to Pills in Diabetes?

Volume:12   Issue: 4
Pp: 617-626
Sibel Ertek and Sevki Cetinkalp
DOI: 10.2174/15701611113119990122

Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview

Volume:12   Issue: 4
Pp: 627-641
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis and Dimitri P. Mikhailidis
DOI: 10.2174/15701611113119990131

Pre-CKD- Do we Need Another Hero?

Volume:12   Issue: 4
Pp: 642-648
Jolanta Malyszko and Maciej Banach
DOI: 10.2174/15701611113119990123

Controversies on HDL: Should it be a Target Biomarker in Patients with Lipid Disorders?

Volume:12   Issue: 4
Pp: 649-652
Stephen J. Nicholls, Jordan Andrews and MyNgan Duong
DOI: 10.2174/1570161112999140411131155